Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses

被引:201
作者
Costa, Luis A. [1 ]
Eiro, Noemi [1 ]
Fraile, Maria [1 ]
Gonzalez, Luis O. [1 ,2 ]
Saa, Jorge [1 ]
Garcia-Portabella, Pablo [1 ]
Vega, Belen [1 ]
Schneider, Jose [3 ]
Vizoso, Francisco J. [1 ]
机构
[1] Fdn Hosp Jove, Unidad Invest, Avda Eduardo Castro 161, Gijon 33920, Asturias, Spain
[2] Fdn Hosp Jove, Dept Anat Pathol, Gijon, Spain
[3] Univ Valladolid, Dept Obstet & Gynecol, Valladolid, Spain
关键词
Regenerative medicine; Aging diseases; Diabetes; Lupus; Secretome; Conditioned medium; Extracellular vesicles; Exosomes; ADIPOSE-DERIVED STEM; HUMAN BONE-MARROW; EXPRESSING INTERFERON-BETA; UMBILICAL-CORD BLOOD; FREE LYSATE INHIBIT; LOW-OXYGEN TENSION; STROMAL CELLS; IN-VITRO; PROGENITOR CELLS; GROWTH-FACTOR;
D O I
10.1007/s00018-020-03600-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mesenchymal stem cells (MSC) are present in all organs and tissues. Several studies have shown the therapeutic potential effect of MSC or their derived products. However, the functional heterogeneity of MSC constitutes an important barrier for transferring these capabilities to the clinic. MSC heterogeneity depends on their origin (biological niche) or the conditions of potential donors (age, diseases or unknown factors). It is accepted that many culture conditions of the artificial niche to which they are subjected, such as O(2)tension, substrate and extracellular matrix cues, inflammatory stimuli or genetic manipulations can influence their resulting phenotype. Therefore, to attain a more personalized and precise medicine, a correct selection of MSC is mandatory, based on their functional potential, as well as the need to integrate all the existing information to achieve an optimal improvement of MSC features in the artificial niche.
引用
收藏
页码:447 / 467
页数:21
相关论文
共 257 条
  • [1] Abdeen AA, 2014, TISSUE ENG PT A, V20, P2737, DOI [10.1089/ten.TEA.2013.0661, 10.1089/ten.tea.2013.0661]
  • [2] Afanasyev BV., 2009, Cellular Therapy and Transplantation (CTT), V1, DOI [DOI 10.3205/CTT-2009-EN-000029.01, 10.3205/ctt-2009-en-000029.01]
  • [3] Both human and mouse mesenchymal stem cells promote breast cancer metastasis
    Albarenque, Stella Maris
    Zwacka, Ralf Michael
    Mohr, Andrea
    [J]. STEM CELL RESEARCH, 2011, 7 (02) : 163 - 171
  • [4] Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies
    Alcayaga-Miranda, Francisca
    Cuenca, Jimena
    Khoury, Maroun
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [5] Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position
    Alvarez, Diana
    Levine, Melanie
    Rojas, Mauricio
    [J]. STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS, 2015, 8 : 61 - 65
  • [6] Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly
    Amable, Paola Romina
    Telles Teixeira, Marcus Vinicius
    Vieira Carias, Rosana Bizon
    Granjeiro, Jose Mauro
    Borojevic, Radovan
    [J]. STEM CELL RESEARCH & THERAPY, 2014, 5
  • [7] Application of standard cell cultures and 3D in vitro tissue models as an effective tool in drug design and development
    Amelian, Aleksandra
    Wasilewska, Katarzyna
    Megias, Diego
    Winnicka, Katarzyna
    [J]. PHARMACOLOGICAL REPORTS, 2017, 69 (05) : 861 - 870
  • [8] Ankrum J, 2020, SCI TRANSL MED, V532, peabb0792
  • [9] Chondrogenic Potential of Subpopulations of Cells Expressing Mesenchymal Stem Cell Markers Derived From Human Synovial Membranes
    Arufe, M. C.
    De la Fuente, A.
    Fuentes, I.
    de Toro, F. J.
    Blanco, F. J.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 111 (04) : 834 - 845
  • [10] Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation
    Attar-Schneider, Oshrat
    Zismanov, Victoria
    Drucker, Liat
    Gottfried, Maya
    [J]. TUMOR BIOLOGY, 2016, 37 (04) : 4755 - 4765